Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.


Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
Arlington, VA 22206

Life & the LawAbortion

Planned Parenthood: “Irreplaceable” and “Lifesaving”?

This is Issue 17 of the On Point Series.


Planned Parenthood: “Irreplaceable” and “Life-Saving”? 


In its most recent annual report, the Planned Parenthood Federation of America makes two fundamental claims, both of which are directly relevant to the question involving continued government funding for its services, approximately $555 million in the fiscal year ending June 30, 2016.[1] These claims are:

  • First, that Planned Parenthood health centers are “an irreplaceable component of our country’s healthcare system”, and;
  • Second, that Planned Parenthood provides “lifesaving care.”

These claims would suggest that Planned Parenthood’s services are unique and not easily available from other providers, and that the level and intensity of services have a direct and measurable impact on the likelihood of fatal occurrences (i.e., deaths).


Scope and Scale


Planned Parenthood, by almost any measure, is a large organization with nearly 650 health centers in the U.S. alone and an international presence through Planned Parenthood Global Health Partners in 12 other nations including Ecuador, Guatemala, Nicaragua, and Peru. It has $1.5 billion in net assets and $1.1 billion in current annual revenue. It is popular enough to receive $258 million dollars in annual private contributions and bequests, nearly half as much as it receives from government grants and service reimbursement. It is entrepreneurial enough to spend more than $73 million annually on fundraising. Its 501 (c)(3) affiliates are politically engaged enough to spend $39 million annually on “Public Policy Programs.”  And it has its own 501 (c)(4) political arm, the Planned Parenthood Action Fund, and related entities that planned to spend another $30 million in the 2016 election cycle.[2] With $165.8 million in management expenses annually, the organization is undoubtedly intensely and strategically managed. But what, exactly, does Planned Parenthood do – and are those services “irreplaceable” and “lifesaving”?


The Service Profile


In 2015, Planned Parenthood health centers saw 2.4 million patients during 4 million clinical visits and provided 9.5 million services.[3] A service is defined as a “unique clinical interaction” – a term vague enough to be insufficient for any health insurance claim.

The largest volume of services (4,266,689, or 44.9% of total services) is for Sexually Transmitted Infection (STI) testing and treatment. According to the annual report, nearly 99% of Planned Parenthood STI services involve testing – not treatment.  Of the 4,266,689 services totaled in this category, only 53,396 involved treatments, split nearly half-and-half between genital warts and “other STI prevention and treatments.”[4] STI testing and treatment are prerequisites for surgical abortions and IUD insertions in some populations.

The second largest volume of Planned Parenthood’s services (2,808,815 or 30% of total services) is for contraception. Of that group of services, 1,936,360 services, or 68.9%, were for reversible contraception clients as follows: oral pill (41%), IUD and implant (16%), progestin-only injectable (15%), combined hormone ring (5%), combined hormone patch (2%), and other (21%).


The third largest volume category of Planned Parenthood services (1,317,582, or 13% of total services) is for “other women’s health services.” 1,079,836 of those services, or 81.9%, are pregnancy tests, likewise a prerequisite for abortion. There are minuscule numbers of prenatal services and miscarriage care.


Cancer screenings and prevention services (665,234, or 7% of total services) include breast exams (321,700) and pap tests (293,799) and a few other very-low-volume procedures.

Abortion services includes 328,348 abortion procedures, or 3.4 % of total services, though as a percentage of revenue, abortion is a much larger component of the group’s work, with estimates ranging from 10 percent of total revenue to as much as one third of its clinic revenue from all sources.[5] “Other services” (108,309, or 1.1% of total services) includes small numbers of primary care services and nominal numbers of adoption referrals and other procedures.


Planned Parenthood centers are largely focused on contraceptive services, sexually transmitted infection testing, and abortions. There is little or no demonstrable capability for definitive diagnosis or a range of treatments for any disease or condition at Planned Parenthood centers. A breast exam, for example, is a valuable service that women should perform on a regular basis – more frequently, in fact, than the once- or twice-a-year visit made to a family planning provider.  But such exams are insufficient for a confirmatory diagnosis of breast cancer. Additional diagnostic testing or technology (e.g., mammogram, biopsy) is required. Planned Parenthood centers can only refer to other providers to make this determination. Planned Parenthood does not maintain the resources to diagnose or treat breast cancer, or any other type of cancer for that matter.[6] The role of Planned Parenthood in the range of diagnostic and treatment activity, which is known as “medical care” or “health services,” is neither wide (covering a range of diseases or conditions) nor deep (having the capacity to move a patient from diagnosis to treatment). With the exception of abortion, Planned Parenthood does not provide any service that is not easily available from alternative providers. Their highest volume service, STI testing, is one of the core activities of local public health departments which outnumber Planned Parenthood clinics by a ratio of 4 to 1 nationally.[7]


Market Share


Market share is one of the key metrics in determining the success of an organization. Basically, market share demonstrates what percentage of the market potential (total services provided or products sold) is captured by the organization. Market share is also an objective way to measure reliance of the total market of clients or customers on any provider of goods or services.


For most of the services offered at their centers, Planned Parenthood provides a very tiny fraction of the national annual incidence of those services. For example, in 2015, Planned Parenthood provided 654,218 HIV tests, one of their highest-volume services. However, the Henry J. Kaiser Family Foundation estimates that 16% of Americans between the ages of 18 and 64, or about 45 million people, were tested that year for HIV.[8] This means Planned Parenthood has less than 1.4% of the market share. Similarly, Planned Parenthood provided 293,799 pap tests out of a National Center for Health Statistics-estimated total of 55-60 million in the U.S., also less than 1% market share.[9] The absolute numbers and market shares of the majority of services listed by Planned Parenthood are nominal or non-material as a percentage of national totals.


There are only two service categories in which Planned Parenthood can be said to provide a meaningful share of the national market.  The first is for abortion, where there is no question of the national market domination of Planned Parenthood. In 2015, Planned Parenthood performed more than one third (35.4%) of all the induced abortions in the U.S. To place that national market share into some comparative perspective, consider a few examples of goods and services, U.S. market leaders, and their market shares: automobile sales, General Motors (17.3%)[10]; LCD televisions, Samsung (21.6%)[11]; health insurance, United Health Group (12.3%)[12]; grocery food and beverage chains, Walmart (17.3%)[13]; life insurance, MetLife Insurance (7.7%)[14]; and domestic air travel, Southwest Airlines (19.1%)[15]. The level of market dominance for abortions demonstrated by Planned Parenthood could be taught in business schools as the ultimate example of strategic planning and execution.  It is a defining activity.


The second is in the provision of reversible contraceptive services. In 2015, Planned Parenthood provided 8.2% of the 9.7 million prescriptions for the oral pill; 7.0% of the 4.4 million long-acting IUDs and implants; 17.1% of the 1.7 million progestin-only injectables; 5.1% of the 1.9 million hormone rings; and 3.9% of the nearly 1 million hormone patches[16]. Among the subset of women who are contraceptive clients served at publicly funded clinics, Planned Parenthood claims a 31.9% (1,996,940 out of 6,246,290) market share.[17] It should be noted that the state of California alone provides 35.6% of all Planned Parenthood contraceptive clients, and that the majority (55.7%) of its contraceptive clients nationally come from only five states: California, New York, Texas, Washington, and Pennsylvania.[18] This geographically skewed concentration of services suggests that the Planned Parenthood image as the provider of last resort in many communities may be deceptive. In fact, Planned Parenthood is most heavily invested in high-population areas which are rich in alternative providers.[19]




Planned Parenthood is unquestionably, and clearly by design, the dominant provider of induced abortions in the U.S.; it is their “raison d’etre.”  Between 2011 and 2016, Planned Parenthood has increased its service-to-unique-client ratios for contraceptive services (+2.1%), STI testing (+19%), and abortions (+25%). During that same period, other Planned Parenthood services were deemphasized as shown by the decline in service-to-client ratios for breast exams (-37%) and pap tests (-37%). As their total client volume has decreased, Planned Parenthood has maintained contraception and STI testing as important support services for their major objective — abortion. No service Planned Parenthood provides is irreplaceable. Ironically, the elimination of abortion services is the only action Planned Parenthood could take that could be legitimately considered as “lifesaving.”


James Studnicki, Sc.D., MPH, MBA is Vice President and Director of Data Analytics for the Charlotte Lozier Institute. Charles A. Donovan is President of the Charlotte Lozier Institute.


[1] Planned Parenthood Annual Report 2016 at p. 28.  See  The report is for the fiscal year ending June 30, 2016.  The government funding figure includes both federal and state receipts.

[2] Parenthood+Action+Fund+%2415+million+2016&gs_l=psy-ab.3…4571.5355.0.6251.….0…1.1.64.psy-ab..1.0.0.gel2B1NKFBE.

[3] Ibid., p.7.  The report notes that 65% of Planned Parenthood’s contraceptive clients made two or more visits in the single year covered.  Clients may receive multiple services (contraception, pregnancy, STI testing) and each of these services is counted separately toward the 9.5 million total (Annual Report, p. 24).  The period covered in this summary is from October 1, 2014 to September 30, 2015, not the general time span for the Report itself.

[4] Ibid., p. 25.

[5] Rachael Larrimore, “The Most Meaningless Abortion Statistic Ever,”, May 7, 2013, at

[6] Michelle Ye Hee Lee, “The repeated, misleading claim that Planned Parenthood ‘provides’ mammograms,” The Washington Post, October 2, 2015, at

[7] U.S. Centers for Disease Control, “United States Public Health 101,” November 2013, at  There were 2,565 local health departments in the U.S. according to data collected in the 2010 National Profile of Local Health Departments (NACCHO, 2011).

[8] Henry J. Kaiser Family Foundation, “HIV Testing in the United States,” June 23, 2017, at

[9] National Center for Health Statistics. Health, United States, 2016: With Chartbook on Long-term Trends in Health. Hyattsville, MD. May 2017, at

[10] Edmunds, “Market Share by Manufacturer,” November 17, 2016, at

[11] Statista, “TV set sales revenue share in North America by brand in 2015,” 2017, at

[12] Statista,  “Market share of leading health insurance companies in the United States in 2015, by direct premiums written,” 2017, at

[13] Statista, “Market share of U.S. food and beverage purchases in 2016, by company,” 2017, at

[14] Carpenter, William J. “Biggest Life Insurance Companies in the US (PRU, MET),” September 25, 2015, at

[15] “Leading airlines in the United States from 2010 to 2016, based on domestic market share,” 2017, at

[16] National Health Statistics Report, #86 November 10, 2015. Current use and variation by selected contraceptive methods, women aged 15-44, U.S. 2011-2013. Daniels, Daugherty, Jones et al.

[17] Frost, JJ. et al. Publicly Funded Contraceptive Services at U.S. Clinics, 2015, New York: Guttmacher Institute, 2017, at

[18] Ibid.

[19] See; and “Fact Sheet: Reallocating Planned Parenthood’s Federal Funding to Comprehensive Health Centers,” (March 7, 2017) at

Latest Posts

July 11, 2024 Abortion Reporting: Alaska (2023) July 2, 2024 Experts: No Evidence Behind “Induced Abortion Is Evidence-Based Medical Care” Argument Experts: No Evidence Behind “Induced Abortion Is Evidence-Based Medical Care” Argument July 1, 2024 Is Induced Abortion Evidence-Based Medical Practice?

You Might Also Be Interested In

The State of Abortion Reporting in 2024 America: Still Striving Toward a Better National Standard

June 26, 2024

Written Testimony of Dr. Ingrid Skop on Interstate Travel for Abortion

charlotte-lozier-institute Charlotte Lozier Institute
June 18, 2024
United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

May 23, 2024

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.